X0306 4 2022-11-15 0 0001420800 Enovis CORP ENOV 0001205249 PRYOR DANIEL A 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808 0 1 0 0 EVP, Strategy & Business Dev. Common stock, par value $0.001 2022-11-15 4 M 0 67421 45.06 A 143152 D Common stock, par value $0.001 2022-11-15 4 S 0 67421 54.576 D 75731 D Common stock, par value $0.001 932 I By 401k plan Common stock, par value $0.001 333 I By trust for daughter Common stock, par value $0.001 333 I By trust for daughter Common stock, par value $0.001 333 I By trust for son Employee Stock Option (right to buy) 45.06 2022-11-15 4 M 0 67421 0.00 D 2023-11-16 Common stock, par value $.001 67421 0 D Holdings reflect the adjustments that occurred as of April 4, 2022 in connection with the spin-off of ESAB Corporation by the Issuer. In connection with the spin-off, each outstanding restricted stock unit was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded down to the nearest whole unit. In addition, holdings have been updated to reflect the impact of the one-for-three reverse stock split effected by the Issuer on April 4, 2022. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.47 to $55.01, inclusive. The reporting person undertakes to provide to Enovis Corporation, any security holder of Enovis Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vests in equal installments on the first, second and third anniversaries of the grant date, which was 11/15/2015 /s/ Brian P. Hanigan, attorney-in-fact 2022-11-17